Fluorouracil, Doxorubicin, and Cyclophosphamide Followed by Tamoxifen as Adjuvant Treatment for Patients with Stage IV Breast Cancer with No Evidence of Disease-Reference-Cited by-同舟云学术

Fluorouracil, Doxorubicin, and Cyclophosphamide Followed by Tamoxifen as Adjuvant Treatment for Patients with Stage IV Breast Cancer with No Evidence of Disease

Published:2002-01 Issue:1 Volume:8 Page:2-9
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast Journal

Author:

Rivera Edgardo,Holmes Frankie A.,Buzdar Aman U.,Asmar Lina,Kau Shu-Wan,Fraschini Giuseppe,Walters Ronald,Theriault Richard L.,Hortobagyi Gabriel N.

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1524-4741.2002.08002.x/fullpdf

Reference21 articles.

1. Combined modality approach in breast cancer with isolated or multiple metastases

2. Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients

3. Prognosis and Treatment of Loco-Regional Breast Cancer Recurrences: Critical Considerations on 120 Cases

4. The Implications of Local Recurrence of Breast Cancer as the First Site of Therapeutic Failure

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapeutic Protocols for the Treatment of Breast Cancer;Chemotherapy Protocols and Infusion Sequence;2022

2. Therapeutic Strategies for Human Epidermal Receptor-2 Positive Metastatic Breast Cancer: A Literature Review;Cureus;2020-08-02

3. Long-Term Survival and Cure in Distant Metastatic Breast Cancer;Oncology;2019

4. Role of Operative Management in Stage IV Breast Cancer;Surgical Clinics of North America;2018-08

5. A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer;Biomedicine & Pharmacotherapy;2017-11